A NOMOGRAM TO CLASSIFY MEN WITH LOWER URINARY TRACT SYMPTOMS USING URINE FLOW AND NONINVASIVE MEASUREMENT OF BLADDER PRESSURE

2005 ◽  
Vol 174 (4 Part 1) ◽  
pp. 1323-1326 ◽  
Author(s):  
C.J. GRIFFITHS ◽  
C. HARDING ◽  
C. BLAKE ◽  
S. McINTOSH ◽  
M.J. DRINNAN ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Urine Flow ◽  
Noninvasive Measurement ◽  
Bladder Pressure ◽  
Urinary Tract Symptoms ◽  
Lower Urinary

scholarly journals Evaluation of the efficacy and tolerability of combination therapy for lower urinary tract symptoms in patients with chronic prostatitis and benign prostatic hyperplasia

2021 ◽  
Vol 14 (2) ◽  
pp. 37-42
Author(s):  
I.V. Vinogradov ◽  
◽  
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract Symptoms ◽  
Chronic Prostatitis ◽  
Lower Urinary Tract ◽  
Combined Therapy ◽  
Prostatic Hyperplasia ◽  
Urine Flow ◽  
Group I ◽  
Urinary Tract Symptoms ◽  
Lower Urinary

Introduction. Chronic prostatitis (CP) is one of the most common urological diseases; CP often accompanies benign prostatic hyperplasia (BPH). Quite often in patients with CP, obstructive, irritative and urethral symptoms are detected. However, there is simply no effective therapy for CP. Despite the lack of data on the proven effectiveness of herbal medicine in international clinical trials, this treatment for CP and BPH remains popular. Aim. To study clinical efficacy and safety of CHINCH herbal drug in treatment of patients with CP and BPH. Materials and methods. 820 men from 13 clinical centers of the Russian Federation with lower urinary tract symptoms associated with CP and BPH were included in the study. The patients were divided into 2 groups. Group I included 423 patients who were administered a complex therapy with Tamsulosin (0.4 mg, 1 capsule once a day for 2 months) and CHINCH (2 capsules 2 times a day for 2 months). Group II consisted of 397 patients who had only Tamsulosin (0.4 mg, 1 capsule once a day for 2 months). Results. According to uroflowmetry, the patients from the group with combined therapy showed significantly better average values of the maximum urine flow rate (Qmax) at the end of 2 months of the therapy, than the initial values in the group, as well as the values of the monotherapy group (p<0.05). All patients noted an increase in the urine flow rate after a month of taking drugs with an increase in the effect by the end of the program. All patients who were included in the observational program, marked an improvement in the quality of life (QoL). The QоL value in the group I became significantly higher (p <0.05) compared with the initial and intermediate values, as well as with the same values in the monotherapy group. All patients noted that the prescribed therapy was well tolerated. Discussion. The study showed, that both subjective and objective criteria for assessing the disease course improved in patients using our approach of complex therapy for lower urinary tract symptoms, associated with CP and BPH (CHINCH in combination with Tamsulosin). These results indicate that the use of herbal therapy in combination with basic therapy with Tamsulosin is an effective and safe treatment method for lower urinary tract symptoms, caused by CP and BPH. Our results are consistent with the data of other researchers. Conclusions. Combined therapy with an alpha-adrenergic blocker in combination with CHINCH, compared with monotherapy, can help to achieve a faster and more significant result in the relief of lower urinary tract symptoms caused by CP and BPH. The combined therapy allows to achieve a higher level of Qmax, IPSS and QOL values within a month, and by the end of the second month - to enhance this effect. The use of CHINCH is not accompanied by adverse effects and can be administered for a long time to relieve lower urinary tract symptoms in patients with CP and BPH.

scholarly journals Pelvic floor electromyography and urine flow patterns in children with vesicoureteral reflux and lower urinary tract symptoms

2018 ◽  
Vol 44 (6) ◽  
pp. 1207-1214 ◽  
Author(s):  
Lida Sharifi-Rad ◽  
Seyedeh-Sanam Ladi-Seyedian ◽  
Hossein Amirzargar ◽  
Abdol-Mohammad Kajbafzadeh
Keyword(s):  
Urinary Tract ◽  
Pelvic Floor ◽  
Vesicoureteral Reflux ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Flow Patterns ◽  
Urine Flow ◽  
Urinary Tract Symptoms ◽  
Lower Urinary

scholarly journals An Extremely Rare Case of Lower Urinary Tract Symptoms: Floating Benign Mesenchymal Mass in Abdomen

2017 ◽  
Vol 2017 ◽  
pp. 1-3 ◽  
Author(s):  
Bulent Kati ◽  
Yigit Akin ◽  
Eyyup Sabri Pelit ◽  
Mehmet Ogur Yilmaz
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Urine Flow ◽  
Urinary Tract Symptoms ◽  
Us Findings ◽  
The Right ◽  
Enhanced Computed Tomography ◽  
Laparoscopic Transperitoneal ◽  
Lower Urinary

A 48-year-old man admitted to the urology outpatient clinic with major symptoms of right-side pain and intermittent lower urinary tract symptoms (LUTSs) such as low urine flow rate, dysuria, and frequency. Uroflowmetry showed low urine flow, and laboratory tests revealed no pathology. Ultrasound (US) showed a 7 cm calcific mass above the bladder and a kidney cyst with a diameter of 5.3 cm in the upper pole of the right kidney. Enhanced computed tomography confirmed the US findings. Laparoscopic transperitoneal renal cyst decortication was performed. There was no sign of additional tumors. An independent mass in the abdomen was diagnosed, and the mass was removed. Based on the pathology, the diagnosis was a benign mesenchymal calcific mass. This is the first report of LUTSs due to a free benign mesenchymal mass in the published literature.

scholarly journals Efficiency of sildanefil monotherapy in benign prostatic hyperplasia

2016 ◽  
Vol 69 (11-12) ◽  
pp. 379-383
Author(s):  
Dragan Grbic ◽  
Sasa Vojinov ◽  
Dimitrije Jeremic ◽  
Ivan Levakov ◽  
Senjin Djozic ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Benign Prostatic Hyperplasia ◽  
Symptom Score ◽  
Lower Urinary Tract Symptoms ◽  
International Prostate Symptom Score ◽  
Lower Urinary Tract ◽  
Prostatic Hyperplasia ◽  
Urine Flow ◽  
Urinary Tract Symptoms ◽  
Lower Urinary

Introduction. High incidences of benign prostatic hyperplasia and lower urinary tract symptoms have a high socioeconomic importance. There are several published studies which have proved the efficiency of phosphodiesterase type 5 inhibitors in treatment of benign prostatic hyperplasia and lower urinary tract symptoms. However, more studies are needed to make this therapy the standard option for treating benign prostatic hyperplasia and lower urinary tract symptoms. This study was aimed at exploring changes in International Prostate Symptom Score, post voiding residuum and maximal urine flow in benign prostatic hyperplasia and lower urinary tract symptoms patients treated by sildenafil for benign prostatic hyperplasia and lower urinary tract symptoms. Material and Methods. This study, which was conducted as a prospective, controlled, opened, randomized study, included 30 patients with benign prostatic hyperplasia and lower urinary tract symptoms. Research was conducted at the Department of Urology, Clinical Center of Vojvodina (November 2011 till November 2012). The inclusion criteria were as following: >45 years of age, International Prostate Symptom Score >3, prostatic specific antigen <10, normal urinalysis. The patients were periodically tested for International Prostate Symptom Score, maximal urine flow, and post voiding residuum. Results. Statistically significant changes were found in all parameters: mean International Prostate Symptom Score value improved from 12.8 to 8.6 (32.8% change), mean post voiding residuum value decreased from 49.4 ml to 40.2 ml (18.6% change), mean maximal urine flow value increased from 11.8 ml/s to 12.8 ml/s (8.5% change). Conclusion. Treatment of benign prostatic hyperplasia and lower urinary tract symptoms with a continuous low dose of sildenafil seems to be a good treatment choice for the patients with mild to moderate benign prostatic hyperplasia and lower urinary tract symptoms, especially in the patients with concomitant erectile dysfunction. The authors are aware that their study is limited by a small number of patients. Since there are not too many studies on this topic, they believe that their study will contribute to the determination of place and role of this treatment approach.

scholarly journals Cystometrogram: the low-cost method for rural areas and its benefits

2017 ◽  
Vol 48 (1) ◽  
pp. 80-84
Author(s):  
J Gnanaraj
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract Symptoms ◽  
Rural Areas ◽  
Lower Urinary Tract ◽  
Low Cost ◽  
Northeast India ◽  
Bladder Pressure ◽  
Sufficient Information ◽  
Urinary Tract Symptoms ◽  
Lower Urinary

Cystometrography (CMG) is a means of studying bladder pressure. It is a very useful diagnostic tool in patients with lower urinary tract symptoms for which a simple cystoscopy will not offer sufficient information to form a diagnosis. Of the 8893 patients who underwent screening for urological conditions in rural northeast India during 2010–2014, 280 with lower urinary tract symptoms were investigated with a combination of cystoscopy and CMG. By corresponding CMG diagnosis and treatment, we could examine patients’ overall satisfaction with both the procedure and the treatment. We describe a low-cost method of CMG and our results using this method in rural areas of India.

Does Peak Urine Flow Rate Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from REDUCE

2017 ◽  
Vol 198 (3) ◽  
pp. 650-656 ◽  
Author(s):  
Ross M. Simon ◽  
Lauren E. Howard ◽  
Daniel M. Moreira ◽  
Claus Roehrborn ◽  
Adriana Vidal ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract Symptoms ◽  
Flow Rate ◽  
Lower Urinary Tract ◽  
Urine Flow ◽  
Urine Flow Rate ◽  
Urinary Tract Symptoms ◽  
Lower Urinary
Sign in / Sign up

Export Citation Format

Share Document